In colon and gastric cancer, high CX3CL1 expression is associated with a favorable prognosis, primarily through its recruitment of CD8+ T cells and natural killer (NK) cells, which promote antitumor immunity [31–33]. Here, CX3CL1 is linked to gastric cancer.